We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Early Recognition and Diagnosis of Castleman Disease
Sanam Loghavi, MD
Razelle Kurzrock, MD, FACP
Understanding the Recent Advances in IgAN
Jürgen Floege, MD
Jonathan Barratt, PhD
Almost Like Being There: Updates in IgA Nephropathy From Kidney Week
Howard Trachtman, MD, FASN
Hiddo L. Heerspink, PhD
Exploring Developments in IgAN and FSGS
Richard Lafayette, MD, FACP
Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation
Cara Dolin, MD
Diana Girnita, MD ,PhD
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
Gout Beyond the Joints: What’s the Hidden Danger?
Richard Johnson, MD
Is Managing Gout in the Nephrology Clinic a Challenge?
Abdul Abdellatif, MD, FASN
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
John K. Botson, MD, RPh
Brittany Weber, MD, PhD
Is Gout Hiding in the Nephrology Clinic?
Can You Manage Patients With Uncontrolled Gout More Effectively?
Treat or Refer: Who Is Responsible for Managing Gout?
What Are the Emerging Therapies for Managing Gout?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
What’s New About Gout? Nephrology Perspective
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education